Scientists hunt for depression 'Fingerprint' in the brain
NCT ID NCT07307768
Summary
This early-stage study aims to find a specific brain signal pattern (an EEG biomarker) that shows how ketamine affects people with treatment-resistant depression. Researchers will give small groups of 20 participants different doses of ketamine and measure changes in their depression symptoms and brain activity. The goal is to gather knowledge to help guide future treatment, not to directly treat participants' depression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION (TRD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.